Patents by Inventor Ravi Kacker

Ravi Kacker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220062177
    Abstract: The present disclosure relates to extended release dosage forms of human chorionic gonadotropin (hCG) or derivatives or isoforms thereof. The extended release hCG dosage forms comprise biodegradable polymer microspheres and provide for extended release of hCG over a desired time period.
    Type: Application
    Filed: October 2, 2019
    Publication date: March 3, 2022
    Applicants: InnoCore Technologies Holding B.V., MHB Labs, Inc.
    Inventors: Johan ZUIDEMA, Rob STEENDAM, Joana Catarina Ribeiro ARAUJO, Ravi KACKER, Abraham MORGENTALER
  • Publication number: 20200282008
    Abstract: The invention provides compositions and methods for long term release of gonadotropin-releasing hormone (GnRH) antagonists and uses thereof. Specifically, the invention provides polymer compositions and methods for controlled release of GnRH antagonists.
    Type: Application
    Filed: May 21, 2020
    Publication date: September 10, 2020
    Inventors: Ravi KACKER, Mitchell S. STEINER, Jui-Chen LIN, Andrew Michael CERRO, Christopher A. RHODES
  • Publication number: 20180250354
    Abstract: The invention provides compositions and methods for long term release of Gonadotropin-releasing hormone (GnRH) antagonists and uses thereof. Specifically, the invention provides polymer compositions and methods for controlled release of GnRH antagonists.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 6, 2018
    Inventors: RAVI KACKER, Mitchell S. Steiner
  • Publication number: 20180214507
    Abstract: The invention provides compositions and methods for long term release of Gonadotropin-releasing hormone (GnRH) antagonists, and uses thereof. Specifically, the invention provides polymer compositions and methods for controlled release of GnRH antagonists.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 2, 2018
    Inventors: Ravi Kacker, Mitchell S. Steiner